Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124035523 | 12403552 | 3 | F | 20160225 | 20160726 | 20160525 | 20160729 | PER | US-009507513-1605USA010723 | MERCK | 77.21 | YR | M | Y | 133.79000 | KG | 20160729 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124035523 | 12403552 | 1 | PS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, ONCE | Y | L038682 | 21995 | 100 | MG | FILM-COATED TABLET | 1X | ||||
124035523 | 12403552 | 2 | SS | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Y | 21995 | FILM-COATED TABLET | ||||||||||
124035523 | 12403552 | 3 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 20 MG, BID | U | 0 | 20 | MG | BID | |||||||
124035523 | 12403552 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124035523 | 12403552 | 1 | Diabetes mellitus |
124035523 | 12403552 | 2 | Glycosylated haemoglobin increased |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124035523 | 12403552 | Blood glucose decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124035523 | 12403552 | 1 | 20160225 | 20160225 | 0 |